Table 2: Study withdrawals.
|
Withdrawal reasons |
Policosanol (n = 200)
|
Placebo (n = 200)
|
||
|
|
n |
% |
n |
% |
|
Unwillingness to follow-up |
1 |
0.5 |
0 |
0 |
|
Protocol violation |
4 |
2 |
2 |
1 |
|
Travels abroad |
2 |
1 |
7 |
3.5 |
|
Total of study withdrawals |
7 |
3.5 |
9 |
4.5 |
N number of cases
All comparisons were not-significant (χ2 test)
Protocol violations were due to intake of antihypertensive drugs